Skip to content
akaturk Academic measurement
Sign in Sign up
2025 SJR Q2 JCR Q2 · 3,7 OA 87 matched articles SCIE

Journal detail

Journal of Global Antimicrobial Resistance

Publisher
Elsevier Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 22137165
  • 22137173
Scopus 1,002 SJR
Scopus Q2 SJR Q
WoS Q2 JCR Q
WoS 3,7 JIF
Scopus 60 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 1,002
  • Quartile Q2
  • H-Index 60
  • Cites/doc 3,27
  • Docs (3y) 695
  • Cites (3y) 2.256

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 3,7
  • 5Y JIF 4,1
  • JCI 0,93

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

Areas

WoS categories

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q2 1,002 3,7 4,1 0,93 Q2 60
2024 Q2 Q2 0,992 3,2 3,8 0,92 Q2 55
2023 Q2 Q2 0,88 3,7 3,8 0,9 Q2 55
2022 Q2 Q2 0,879 4,6 4,1 0,89 Q2 55
2021 Q2 Q2 0,763 4,3 3,9 0,85 Q2 55
2020 Q2 Q2 0,917 4 3,6 0,86 Q2 55
2019 Q2 Q2 0,762 2,7 2,6 0,74 Q2 55
2018 — Q3 — 2,5 2,4 0,67 Q3 —
2017 Q2 Q3 0,658 2 1,9 0,5 Q3 55
2016 Q3 Q4 0,522 1,3 1,4 — — 55
2015 Q3 Q4 0,427 1,1 1,1 — — 55
2014 Q3 Q4 0,517 1,1 1,1 — — 55
2013 — — — — — — — 55

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 INFECTIOUS DISEASES SCIE Q2 Q2 44/141
2025 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 120/356
2024 INFECTIOUS DISEASES SCIE Q2 Q2 43/137
2024 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 126/352
2023 INFECTIOUS DISEASES SCIE Q2 Q2 39/132
2023 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 90/354
2022 INFECTIOUS DISEASES SCIE Q2 Q2 36/96
2022 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 71/278
2021 INFECTIOUS DISEASES SCIE Q3 Q2 48/95
2021 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 101/279
2020 INFECTIOUS DISEASES SCIE Q2 Q2 34/93
2020 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 108/276
2019 INFECTIOUS DISEASES SCIE Q3 Q2 51/92
2019 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 133/271
2018 INFECTIOUS DISEASES SCIE Q3 Q3 50/89
2018 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 140/267
2017 INFECTIOUS DISEASES SCIE Q3 Q3 62/88
2017 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 171/261
2016 INFECTIOUS DISEASES SCIE Q4 — 74/84
2016 PHARMACOLOGY & PHARMACY SCIE Q4 — 210/257
2015 INFECTIOUS DISEASES SCIE Q4 — 74/83
2015 PHARMACOLOGY & PHARMACY SCIE Q4 — 218/255
2014 INFECTIOUS DISEASES SCIE Q4 — 70/78
2014 PHARMACOLOGY & PHARMACY SCIE Q4 — 212/255